Skip to main content
. 2020 Mar 12;11(5):1361–1364. doi: 10.1111/1759-7714.13386

Figure 1.

Figure 1

Rvision‐001 study design. DCR, disease control rate; iORR, intracranial ORR; iPFS, intracranial PFS; ORR, objective response rate; OS, overall survival; PD, disease progression; PFS, progression‐free survival; SRS, stereotactic radiosurgery.